Januvia (sitagliptin) tablets

Januvia is a brand-name prescription medication used to manage blood sugar levels in adults with type 2 diabetes. The active ingredient, sitagliptin, belongs to a class of drugs known as DPP-4 inhibitors. It was developed and patented by Merck & Co., a leading global pharmaceutical company based in the United States. While the brand is American, the manufacturing process for such specialized pharmaceuticals often involves a complex global supply chain, with active ingredients and final product packaging occurring in multiple countries, including the USA, Italy, and Puerto Rico, depending on the specific market and facility distribution. Merck remains the primary owner and distributor of the product globally.